The deal marks Lilly’s first in the M&A arena in 2026 as the company diversifies its pipeline beyond obesity drugs.

Mikron Automation and Denver-based Confluent Development have announced the expansion of Mikron Automation’s US headquarters ...

Day One Biopharmaceuticals has concluded its acquisition of Mersana Therapeutics after meeting all the tender offer ...

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

Octapharma has received approval from the US FDA for a new 2-g formulation of Fibryga for use in patients with AFD.

According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...

Zai Lab has received approval from China’s NMPA for the sNDA for Augtyro to treat adult patients with solid tumours ...

Cellenkos has received orphan drug designation from the US FDA for its investigational CK0804 Treg therapy to treat ...

Ypsomed will establish its first manufacturing facility in the US. The company has selected Holly Springs in Wake County, ...

Takeda and Protagonist Therapeutics have jointly submitted a NDA seeking approval from the US FDA for rusfertide to treat ...

Reporter Ross Law and editors Abigail Beaney and Robert Barrie reflect on a busy 2025, along with discusing forecasts for ...

Arrowhead Pharmaceuticals has received authorisation from Health Canada for its siRNA medicine, Redemplo, for adults with FCS ...